CD95L confers immune priviledge to liver grafts which are spontaneously accepted.
Fändrich
F
F
Department of General and Thoracic Surgery, University of Kiel, Germany.
Lin
X
X
Zhu
X
X
Klöppel
G
G
Parwaresch
R
R
Kremer
B
B
D000818:Animals; D017209:Apoptosis; D053222:Fas Ligand Protein; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology; D007108:Immune Tolerance; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000276:immunology*; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology; D014158:Transcription, Genetic; D014184:Transplantation, Homologous / Q000276:immunology / Q000473:pathology; D014185:Transplantation, Isogeneic / Q000276:immunology / Q000473:pathology; D019014:fas Receptor / Q000096:biosynthesis / Q000276:immunology*
D053222:Fas Ligand Protein; C505662:Faslg protein, rat; D008562:Membrane Glycoproteins; D019014:fas Receptor